Cell therapy · FDA · US patients · 2030
Customized stem cell therapy for all US patients
Evidence first, for patients, clinicians and researchers: what FDA has approved, the trial results behind it, and how to tell real therapy from an unproven clinic.
Curated by Dr. Javid Ur Rahaman, Head of Applied Intelligence, AAI Applied Agentic Intelligence Research Labs®
Who are you?
I am one of the
Patients & families
Find out what is proven, what is not, and how to spot an unsafe clinic.
I am one of the
Clinicians
Look up approved products by condition, the evidence behind them, and where to refer.
I am one of the
Researchers & sponsors
Work out your regulatory tier and plan the route to an approved product.
Explore
Successful cases
39 successful cases, from CRISPR-edited stem cells to stem-cell-derived islets, with outcome numbers and sources.
Approved products directory
Search all 55 FDA-approved cellular and gene therapy products.
Regulatory navigator
How FDA regulates cell and tissue products, with a 361 vs 351 self-check.
Verify a clinic
An interactive checklist to tell an FDA-compliant program from an unproven clinic.
Pathways to patients
From preclinical work to IND, expanded access, RMAT and BLA approval.
2030 care-delivery roadmap
A scenario for how approved, customized therapies could reach community settings.